CASI Pharmaceuticals, Inc. (CASI) Stock price, Description, News & Info

#Thinksabio latest news

CASI Pharmaceuticals Announces FDA Clearance of IND Application for CID-103 in Renal Allograft Antibody-Mediated Rejection (AMR)